Flash Finance

Max Healthcare Institute LimitedMAXHEALTHCorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹846.00
MCap ₹82,342 Cr · P/E 114.7
Max Healthcare Institute Limited — Stock analysis & AI research Max Healthcare Institute Limited — Multibagger AI analysis Max Healthcare Institute Limited — Seasonality — best & worst months Max Healthcare Institute Limited — Technical indicators & charts Max Healthcare Institute Limited — Technical setup — score, trend, support & resistance Max Healthcare Institute Limited — Live exchange announcements
📋 High Operating Margin Stocks📋 Mid Cap Stocks List 📈 RSI Oversold Stocks📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks📈 Stocks Near 52-Week Low ⚖️ vs Apollo Hospitals⚖️ vs Aster DM 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹783 Cr
Sales · Jun 2026
+12.8% YoY
₹182 Cr
Operating Profit · Jun 2026
-2.8% YoY
23.3%
OPM % · Jun 2026
-13.7% YoY
₹168 Cr
Net Profit · Jun 2026
+0.9% YoY
₹1.72
EPS · Jun 2026
+0.6% YoY

📝 Max Healthcare Institute Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Max Healthcare Institute Limited reported revenue of ₹783 crore for the quarter ended June 2026 (Q1 FY27), up 12.8% from ₹694 crore in the same quarter last year, and up 6.8% sequentially over the March 2026 quarter.

Net profit rose 0.9% year-on-year to ₹168 crore, from ₹166 crore. Earnings per share (EPS) came in at ₹1.72.

Operating profit stood at ₹182 crore — an operating margin (OPM) of 23.3%, compared with 27.0% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Max Healthcare Institute Limited posted revenue of ₹2,875 crore, a growth of 7.9% over FY25, with a net profit of ₹716 crore (up 2.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,963 crore with a net profit of ₹718 crore.

Valuation snapshot

At the current price of ₹846.00, MAXHEALTH has a market capitalisation of ₹82,342 crore and a trailing P/E of about 114.7.

Within the Medical Care Facilities industry, it is the 2nd-largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 23.71%, foreign institutional investors (FIIs) 40.52%, domestic institutional investors (DIIs) 31.00%, public shareholders 4.76% of Max Healthcare Institute Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹82,342 Cr
Current Price ?
₹846.0
P/E ?
114.69above ind
Industry P/E ?
56.40
P/B ?
9.21
P/S ?
27.79
P/FCF ?
538.18
Enterprise Value ?
₹83,167 Cr
EV/EBITDA ?
101.99
PEG ?
57.34
Earnings Yield ?
0.8%
Dividend Yield ?
0.18%
Profitability & Returns
Sales (TTM) ?
₹2,963 Cr
OPM ?
27.5%
Profit after tax (TTM) ?
₹718 Cr
EPS (TTM) ?
₹7.38
ROCE ?
10.0%
ROE ?
8.0%
ROA ?
6.6%
Growth
Sales — latest qtr ?
₹783 Cr
PAT — latest qtr ?
₹168 Cr
YoY qtr sales growth ?
12.8%
YoY qtr profit growth ?
0.9%
Sales growth (3y) ?
15%
Sales growth (5y) ?
23%
Profit growth (3y) ?
2%
Profit growth (5y) ?
63%
Financial Health
Debt ?
₹825 Cr
Debt to Equity ?
0.09
Interest Coverage ?
17.1
Current Ratio ?
N/A
Ownership
Promoter holding ?
23.71%
Change in promoter holding ?
-0.03%
Pledged percentage ?
N/A
Market
Return 3 months ?
-22.4%
Return 6 months ?
-16.0%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 482507544597591610621686697659694737711733783 +12.8% +6.8%
Operating Profit 154154160203200199198225236175188214204215182 -2.8% -15.1%
Other Income 44414348431384313492988047839192 +15.3% +1.2%
Interest 1314141310158823999111112 +30.5% +9.7%
Depreciation 283028283032303233363537363537 +3.3% +4.6%
Profit Before Tax 157151161210203291203318198227223216225260226 +1.4% -13.1%
Net Profit 122126126161158242154231138177166160187203168 +0.9% -17.4%
EPS 1.261.301.301.661.632.491.592.381.421.821.711.651.922.091.72 +0.6% -17.7%
OPM % 31.9% 30.3% 29.4% 34.0% 33.9% 32.7% 31.9% 32.7% 33.8% 26.5% 27.0% 29.0% 28.7% 29.3% 23.3% -13.7% -20.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹2,663 Cr ₹2,875 Cr ₹2,963 Cr +7.9%
Operating Profit ₹833 Cr ₹821 Cr ₹815 Cr -1.5%
OPM % 31.29% 28.55% 27.52% -8.8%
NPM % 26.32% 24.92% 24.23% -5.3%
Other Income ₹367 Cr ₹302 Cr ₹314 Cr -17.7%
Depreciation ₹131 Cr ₹143 Cr ₹144 Cr +9.3%
Interest ₹49 Cr ₹40 Cr ₹42 Cr -18.6%
EBIT ₹702 Cr ₹677 Cr ₹671 Cr -3.5%
PBT ₹947 Cr ₹924 Cr ₹927 Cr -2.4%
Tax ₹197 Cr ₹150 Cr ₹152 Cr -23.5%
Net Profit ₹701 Cr ₹716 Cr ₹718 Cr +2.2%
EPS ₹7.21 ₹7.37 ₹7.38 +2.2%
Material Cost ₹421 Cr ₹486 Cr ₹514 Cr +15.6%
Employee Cost ₹372 Cr ₹395 Cr ₹405 Cr +6.1%
Extraordinary Items ₹-74 Cr ₹-16 Cr ₹-16 Cr +78.8%

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 971972972973 +0.1%
Reserves 6,0716,7097,3177,967 +8.9%
Borrowings 534443612825 +34.8%
Other Liabilities 8459451,0651,125 +5.6%
Total Liabilities 8,4209,0699,96710,890 +9.3%
Fixed Assets 4,4854,7174,8714,939 +1.4%
CWIP 103235277479 +72.9%
Investments 1,4751,9152,6142,626 +0.5%
Other Assets 2,3582,2022,2062,847 +29.1%
Total Assets 8,4209,0699,96710,890 +9.3%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 696613598503 -15.9%
Cash from Investing Activity -843-806-873-426 +51.2%
Cash from Financing Activity -54-246-2939 +234.5%
Net Cash Flow -201-438-304116 +138.2%
Free Cash Flow 579156344153 -55.5%
CFO/OP 134%100%94%86% -8.5%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 27324053 +32.5%
Inventory Days 31242018 -10.0%
Days Payable 226225191165 -13.6%
Cash Conversion Cycle -169-169-130-94 +27.7%
Working Capital Days -45-32-24-16 +33.3%
ROCE % 9%12%13%10% -23.1%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 23.74%23.74%23.72%23.71%23.71% +0.0%
FIIs 54.76%51.80%50.55%45.39%40.52% -10.7%
DIIs 17.41%20.03%21.20%26.32%31.00% +17.8%
Public 4.09%4.43%4.52%4.58%4.76% +3.9%
No. of Shareholders 1,62,1191,80,8912,03,8372,16,9962,22,167 +2.4%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Max Healthcare Institute Limited's revenue in Q1 FY27?
Max Healthcare Institute Limited reported revenue of ₹783 crore for the quarter ended June 2026 (Q1 FY27), up 12.8% from ₹694 crore in the same quarter last year, and up 6.8% sequentially over the March 2026 quarter.
What was Max Healthcare Institute Limited's net profit in Q1 FY27?
Net profit rose 0.9% year-on-year to ₹168 crore, from ₹166 crore. Earnings per share (EPS) came in at ₹1.72.
What is MAXHEALTH's market capitalisation and P/E ratio?
At the current price of ₹846.00, MAXHEALTH has a market capitalisation of ₹82,342 crore and a trailing P/E of about 114.7.
Who owns Max Healthcare Institute Limited? (shareholding pattern)
As of Sep 2026, promoters held 23.71%, foreign institutional investors (FIIs) 40.52%, domestic institutional investors (DIIs) 31.00%, public shareholders 4.76% of Max Healthcare Institute Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI